USD 10.25
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 774.95 Million | 1.04 Billion | 811.48 Million | 907.68 Million | 1.08 Billion | 985.2 Million |
Net Income | 309.01 Million | 616.23 Million | 655.44 Million | 555.68 Million | 475.12 Million | 313.36 Million |
Depreciation & Amortization | 785.84 Million | 722.04 Million | 626.42 Million | 621.55 Million | 599.03 Million | 560.23 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -319.91 Million | -289.51 Million | -470.38 Million | -269.55 Million | 15.69 Million | 1.01 Billion |
Investing Cash Flow | -2.9 Billion | -1.91 Billion | -1.96 Billion | -1.63 Billion | -568.04 Million | -587.26 Million |
Investments in PPE | -4.11 Billion | -2.34 Billion | -2.37 Billion | -1.54 Billion | -1.2 Billion | -903.72 Million |
Acquisitions | 1.34 Billion | 306.19 Million | 527.57 Million | 492.61 Million | 485.88 Million | 226.01 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -131.7 Million | 124.78 Million | -117.16 Million | -582.73 Million | 155.8 Million | 90.45 Million |
Financing Cash Flow | 2.36 Billion | 965.79 Million | 1.67 Billion | 674.5 Million | -499.27 Million | -236.24 Million |
Debt repayment | -1.2 Billion | -1.73 Billion | -135.69 Million | -796.6 Million | -143.55 Million | -166.78 Million |
Dividends payments | -66.39 Million | -155.05 Million | -114.08 Million | -106.63 Million | -98.68 Million | -112.94 Million |
Common Stock Repurchased | -61.68 Million | - | - | - | - | - |
Common Stock Issuance | 993.22 Million | - | - | - | - | - |
Other Financing Activities | 2.7 Billion | 2.86 Billion | 1.92 Billion | 1.57 Billion | -257.03 Million | 43.48 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 1.19 Billion | 1 Billion | 474.38 Million | 581.75 Million | 551.54 Million | 388.06 Million |
Cash at end of period | 1.4 Billion | 1.17 Billion | 1 Billion | 474.38 Million | 581.75 Million | 551.54 Million |
Capital Expenditure | -4.11 Billion | -2.34 Billion | -2.37 Billion | -1.54 Billion | -1.2 Billion | -903.72 Million |
Effect of forex changes on cash | -36.7 Million | 72.21 Million | 6.44 Million | -52.17 Million | 7.67 Million | 1.79 Million |
Net cash flow / Change in cash | 208.31 Million | 168.14 Million | 529.4 Million | -107.37 Million | 30.21 Million | 163.48 Million |
Free Cash Flow | -3.33 Billion | -1.3 Billion | -1.56 Billion | -639.58 Million | -119.86 Million | 81.47 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 142.05 Million | 68 Million | 309.01 Million | 114.59 Million | 365.17 Million | 14.82 Million |
Depreciation & Amortization | 201.78 Million | 199 Million | 785.84 Million | 197.89 Million | 192.2 Million | 192.79 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 121 Million | -121 Million | - | 128 Million | -128 Million | 144 Million |
Other non-cash items | -415.83 Million | 79 Million | -319.91 Million | -55.24 Million | -172.96 Million | -220.5 Million |
Investing Cash Flow | -797.77 Million | -1.04 Billion | -2.9 Billion | -504.21 Million | -504.21 Million | -591.04 Million |
Investments in PPE | -2.2 Billion | - | -4.11 Billion | -1.1 Billion | -1.1 Billion | -1.9 Billion |
Acquisitions | -1.96 Million | - | 1.34 Billion | -10.56 Million | -10.56 Million | -14.82 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 1.4 Billion | -1.04 Billion | -131.7 Million | 611.32 Million | 611.32 Million | 1.32 Billion |
Financing Cash Flow | 960.28 Million | -109 Million | 2.36 Billion | 286.16 Million | 286.16 Million | 483.08 Million |
Debt repayment | - | - | -1.2 Billion | - | - | - |
Dividends payments | -41.39 Million | - | -66.39 Million | -7.71 Million | -7.71 Million | -50.96 Million |
Common Stock Repurchased | - | - | -61.68 Million | -45 Thousand | -45 Thousand | -6.68 Million |
Common Stock Issuance | - | - | 993.22 Million | - | - | - |
Other Financing Activities | 1 Billion | -109 Million | 2.7 Billion | 293.92 Million | 293.92 Million | 540.74 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 121 Million | -121 Million | - | 128 Million | -128 Million | 144 Million |
Cash at beginning of period | 438.76 Million | 1.37 Billion | 1.19 Billion | - | 1.58 Billion | 1.44 Billion |
Cash at end of period | 647.66 Million | -933 Million | 1.4 Billion | 32.41 Million | 788 Million | 1.3 Billion |
Capital Expenditure | -2.2 Billion | - | -4.11 Billion | -1.1 Billion | -1.1 Billion | -1.9 Billion |
Effect of forex changes on cash | -2.61 Million | - | -36.7 Million | -6.78 Million | -6.78 Million | -23.14 Million |
Net cash flow / Change in cash | 208.9 Million | -2.3 Billion | 208.31 Million | 32.41 Million | -801.87 Million | -135.05 Million |
Free Cash Flow | -2.15 Billion | 225 Million | -3.33 Billion | -847.73 Million | -720.56 Million | -1.77 Billion |
CAAOF
SOBR
FDA
GEBRF
JACK
S24